Kazuo Ando

This inventor holds 20 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Pfizer Corporation, Raqualia Pharma Inc., Asahi Kasei Pharma Corporation. Active years: 1992-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuo Ando. Retrieved from https://idiyas.com/inventor/kazuo-ando

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 2)

% Patents Active = 70.0

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 3.5

ph-index = 5

Forward Citations = 398(Granted Patents)

Location History:

Chita, JP (1992)
Taketoyo, JP (1995)
Handa, JP (1996)
Chita-gun, JP (2001 - 2010)
Aichi-Ken, JP (2003 - 2012)
Nagoya, JP (2021)
Aichi, JP (1998 - 2023)

Company Filing History:

Asahi Kasei Pharma Corporation

patents

where one patent can have more than one assignee

Years Active: 1992-2026

Loading Chart...

Areas of Expertise:

TRPV4 Antagonists

CRHR2 Antagonist

P2X7 Receptor Antagonists

CB2 Receptor Agonists

Anti-Inflammatory Agents

Lipoxygenase Inhibitors

Benzimidazolone Derivatives

Heterocyclic Compounds

Sulfonyl Compounds

Pyrazole Compounds

Azaspiro Derivatives

Fused Cyclic Urea

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673946 - Pyrimidin-4(3H)-one derivatives as TRPV4 antagonists (2026-07-07),

2. 12421191 - 3-hydroxyoxindole derivatives as CRHR2 antagonist (2025-09-23),

3. 12295947 - Tetrahydroquinoline derivatives as P2X7 receptor antagonists (2025-05-13),

4. 11802120 - Fused cyclic urea derivatives as CRHR2 antagonist (2023-10-31),

5. 11077100 - Tetrahydroquinoline derivatives as P2X7 receptor antagonists (2021-08-03),

6. 10093678 - Azaspiro derivatives as TRPM8 antagonists (2018-10-09),

7. 8653063 - N-substituted saturated heterocyclic sulfone compounds with CB2 receptor agonistic activity (2014-02-18),

8. 8138177 - Benzimidazolone derivatives as CB2 receptor ligands (2012-03-20),

9. 7700618 - Sulfonyl benzimidazole derivatives (2010-04-20),

10. 6951876 - Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents (2005-10-04),

11. 6949536 - Sulfonylbenzene compounds as anti-inflammatory/analgesic agents (2005-09-27),

12. 6727238 - Sulfonylbenzene compounds as anti-inflammatory/analgesic agents (2004-04-27),

13. 6649636 - Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents (2003-11-18),

14. 6608095 - Sulfonylbenzene compounds as anti-inflammatory/analgesic agents (2003-08-19),

15. 6603008 - Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents (2003-08-05),

Title: Kazuo Ando: Innovator in Pharmaceutical Chemistry

Introduction

Kazuo Ando is a prominent inventor based in Aichi-ken, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 19 patents. His work focuses on developing innovative compounds that target specific receptors involved in various medical conditions.

Latest Patents

Among his latest patents, Ando has developed 3-hydroxyoxindole derivatives as CRHR2 antagonists. This invention relates to compounds that exhibit antagonistic activities against the CRHR2 receptor, which are useful in treating or preventing disorders associated with this receptor. Additionally, he has patented tetrahydroquinoline derivatives as P2X7 receptor antagonists. This invention includes processes for their preparation and pharmaceutical compositions that utilize these compounds for treating disorders mediated by the P2X7 receptor.

Career Highlights

Kazuo Ando has worked with notable companies in the pharmaceutical industry, including Pfizer Corporation and Raqualia Pharma Inc. His experience in these organizations has allowed him to contribute to the development of innovative therapeutic solutions.

Collaborations

Ando has collaborated with esteemed colleagues such as Tomoki Kato and Akiyoshi Kawai. These partnerships have further enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Kazuo Ando's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.